Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer

References

• Hostetter, R B.; Augustus, L B.; Mankarious, R.; Chi, K F.; Fan, D.; Toth, C.; Thomas, P.; Jessup, J M. Carcinoembyonic antigen as a selective enhancer of colorectal cancer metastases. J. Natl. Cancer Inst. 1990, 82, 380–385. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Fletcher, R H. Carcinoembryonic antigen. Ann. Intern. Med. 1986, 104, 66, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Duffy, M J. CEA as a marker for colorectal cancer: is it clinically useful? Clin. Chem. 2001, 47 (4), 624–630. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Thompson, J A.; Paude, H.; Paxton, R J.; Shively, L.; Padma, A.; Simmer, R L.; Todd, C W.; Riggs, A D.; Shively, J E. Molecular cloning of a gene belonging to the carcinoembryonic antigen family and dissension of a domain model. Proc. Natl. Acad. Sci. U. S. A. 1987, 84 (9), 2965–2969. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zimmerman, W.; Weber, B.; Ortlieb, B.; Rudert, F.; Schempp, W.; Fiebig, H H.; Shively, J E.; von Kleist, S.; Thompson, J A. Chromosome localization of the carcinoembryonic antigen gene family and differential expression in various tumors. Cancer Res. 1987, 48 (9), 2550–2554.
   Web of Science ®Google Scholar
• Zimmerman, W.; Ortlieb, B.; Frederick, R.; von Kleist, S. Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure. Proc. Natl. Acad. Sci. U. S. A. 1987, 84 (9), 2960–2964. [CSA]
   PubMed Web of Science ®Google Scholar
• Fuks, A.; Banjo, C.; Shuster, J.; Freedman, S O.; Gold, P. Carcinoembryonic antigen (CEA): molecular biology and clinical significance. Biochem. Biophys. Acta 1975, 417 (2), 123–152. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gold, P.; Shuster, J.; Freedman, S O. Carcinoembryonic antigen (CEA) in clinical medicine. Cancer 1978, 42, 1399, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fleisher, M.; Nisselbaum, J S.; Loftin, L.; Smith, C.; Schwartz, M K. Roche RIA and Abbott EIA carcinoembryonic antigen assays compared. Clin. Chem. 1984, 30 (2), 200–205. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Adams, W J.; Morris, D L. Carcinoembryonic antigen in the evaluation of therapy of primary and metastatic colorectal cancer. Aust. N. Z. J. Surg. 1996, 66, 515–519. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Koness, J K. CEA: is it of value in colorectal cancer? Rhode Isl. Med. 1995, 78, 164–166. [CSA]
   PubMedGoogle Scholar
• Benchimol, S.; Fuks, A.; Jothy, S.; Beauchemin, N.; Shirota, K.; Stanners, C P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989, 57 (2), 327–334. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kammerer, R.; von Kleist, S. CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-Cell lysis. Int. J. Cancer 1994, 57, 341–347. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wagner, H.; Toth, C.; Steele, G.; Thomas, P. Metastatic potential of human colon cancer cells: relationship to cellular differentiation and carcinoembryonic antigen production. Clin. Exp. Metastasis 1992, 10, 25–31. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cutait, R.; Alves, V A.; Lopes, L C.; Cutait, D E.; Borges, J L.; Singer, J.; da Silva, J H.; Goff, F S. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis. Colon Rectum 1991, 34 (10), 917–920. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zeng, Z.; Cohen, A M.; Urmache, R C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis. Colon Rectum 1993, 36, 1063–1068., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nakane, P K.; Watanabe, T. Distribution of oncodevelopmental markers in neoplastic cells: therapeutic implications. J. Histochem. Cytochem. 1984, 32 (8), 894–898. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• O'Brien, M J.; Zamcheck, N.; Burke, B.; Kirkham, S E.; Saravis, C A.; Gottlieb, L S. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues: assessment of diagnostic value. Am. J. Clin. Pathol. 1981, 75 (3), 283–290. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Denk, G.; Tappeiner, G.; Eckerstorfer, R. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor cell differentiation. Int. J. Cancer 1972, 10, 262–272. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• von Kleist, S.; Chavanel, G.; Burtin, P. Identification of a normal antigen that cross reacts with the carcinoembryonic antigen (CEA). Proc. Natl. Acad. Sci. U. S. A. 1972, 69, 5492
   Google Scholar
• Turberville, C.; Darcy, D A.; Laurence, D J.; Johns, E W.; Neville, A M. Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCA-2: preparation and chemical characterization. Immunochemistry 1973, 10 (12), 841–843. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Newman, E S.; Petras, S E.; Hamilton, J G.; Georgiadis, A.; Hansen, H J. Proceedings: interrelationship of carcinoembryonic antigen and colon carcinoma antigen-3. Cancer Res. 1974, 34 (8), 2125–2130. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tobioka, H.; Isomura, H.; Kokai, Y.; Sawada, N. Polarized distribution of CEA is associated with a tight junction molecule in human colorectal adenocarcinoma. J. Pathol. 2002, 198 (2), 207–212. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schwartz, M K. Cancer markers. In Cancer: Principles and Practice of Oncology; Devita, V T., Ed.; Lippincott: Philadelphia, PA, 1993; 531–542.
   Google Scholar
• Goslin, R.; Steele, G.; MacIntyre, J.; Mayer, R.; Sugarbaker, P.; Cleghorn, K.; Wilson, R.; Zamcheck, N. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann. Surg. 1980, 192 (6), 747–751. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rutanen, E M.; Lindgren, J.; Sipponen, P.; Stenman, V P.; Saksela, E.; Seppala, M. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors. Cancer 1978, 42, 581–590. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ng, I O.; Ho, J.; Pritchett, C J.; Chan, E Y.; Ho, F C. CEA tissue staining in colorectal cancer patients—correlation with plasma CEA, histology staging. Pathology 1993, 25, 219–222. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Alexander, J C.; Silverman, N A.; Chretian, P B. Effect of age and cigarette smoking carcinoembryonic antigen levels. JAMA 1976, 235, 1975–1979. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bates, S E.; Longo, D L. Use of serum tumor markers in cancer diagnosis and management. Semin. Oncol. 1987, 14, 102, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Goldenberg, D M.; Sharkey, R M.; Primus, F J. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. J. Natl. Cancer Inst. 1976, 57, 11–22. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Liu, Y S.; Tobias, R J.; Zurawski, V R., Jr. A more specific, simpler radioimmunoassay for carcinoembryonic antigen, with use of monoclonal antibodies. Clin. Chem. 1985, 31, 191–195. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shuster, J.; Freedman, S O.; Gold, P. Oncofetal antigens: increasing the specificity of the CEA radioimmunoassay. Am. J. Clin. Pathol. 1977, 68 (Suppl. 5), 679–687. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Zucchelli, G C.; Pilo, A.; Chiesa, M R.; Masini, S.; Baccini, C. Minimizing between-kit variability in immunoassay for carcinoembryonic antigen by use of a common standard. Clin. Chem. 1986, 32, 1942–1943. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Scapa, E.; Haagensen, D E., Jr.; Cantarow, W.; Lowenstein, M S.; Thomas, P.; Zamchek, N. Differences in CEA values determined by EIA and RIA in patients with benign and malignant biliary obstructions. Am. J. Clin. Pathol. 1985, 83, 589–593. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Felder, R.; MacMillan, R H., III; Bruns, D C. Two monoclonal-based assays for carcinoembryonic antigen compared. Clin. Chem. 1987, 33, 700–704. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tabuchi, Y.; Deguchi, H.; Imanishi, K. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer: correlation with histopathological variables. Cancer 1987, 59, 1283–1288. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Garcia, A A.; Florentine, B D.; Simon, A J.; Skinner, E C.; Leichman, L W. Xanthogranulomatous cystitis as a cause of elevated carcinoembryonic antigen mimicking recurrent colorectal cancer. Report of a case. Dis. Colon Rectum 1996, 39 (9), 1051–1054. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Moertel, C G.; Fleming, T R.; MacDonald, J S.; Haller, D G.; Laurie, J A.; Tangen, C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancers. JAMA 1993, 270 (8), 943–947. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Steele, G., Jr.; Ellenberg, S.; Hamming, K. CEA monitoring among patients in multi-institutional adjuvant GI therapy protocols. Ann. Surg. 1982, 196, 162–169. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Yeatman, T J.; Bland, K I.; Copeland, E M., III; Hollenbeck, J I.; Souba, W W.; Vogel, S B.; Kimura, A K. Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann. Surg. 1989, 210 (4), 505–512. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Paganuzzi, M.; Onetto, M.; de Paoli, M.; Castagnola, M.; de Salvo, L.; Civalleri, D.; Grossi, C E. Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases. Anticancer Res. 1994, 14 (3B), 1409–1412. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Frikart, L.; Fournier, K.; Mach, J P.; Givel, J C. Potential value of biliary CEA assay in early detection of colorectal adenocarcinoma liver metastases. Eur. J. Surg. Oncol. 1995, 21 (3), 276–279. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Novell, F.; Trias, M.; Molina, R.; Filella, X. Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen. Anticancer Res. 1997, 17 (4A), 2743–2746. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Paul, M A.; Visser, J J.; Mulder, C.; Blomjous, J G.; van Kamp, G J.; Cuesta, M A.; Meijer, S. Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations. Eur. J. Surg. 1996, 162 (6), 483–488. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Paul, M A.; Visser, J J.; Mulder, C.; van Kamp, G J.; Cuesta, M A.; Meijer, S. The use of biliary CEA measurements in the diagnosis of recurrent colorectal cancer. Eur. J. Surg. Oncol. 1997, 23 (5), 419–423. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Gabauer, G.; Muller-Buchholtz, W. CEA and CA 19-9: implications of quantitative marker measurements in tissues for prognosis of colorectal cancer. Cancer Dis. Prev. 2001, 25 (4), 344–351. [CSA]
   Web of Science ®Google Scholar
• Eskelinen, M.; Pasanen, P.; Kulju, A.; Janatuinen, E.; Miettinen, P.; Poikolainen, E.; Tarvainen, R.; Nuutinen, P.; Paakkonen, M.; Alhava, E. Clinical evaluation of serum tumor markers CEA, CA 50 and CA 242 in colorectal cancer. Anticancer Res. 1994, 14 (3b), 1427–1432. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wanebo, H J.; Rao, B.; Pinsky, C M.; Hoffman, R G.; Stearns, M.; Schwartz, M K.; Oettgen, H G. The use of the preoperative carcinoembryonic antigen level as a prognostic indicator to complement pathologic staging. N. Engl. J. Med. 1978, 299 (9), 448–451. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stevens, D P.; MacKay, I R.; Cullen, K J. Carcinoembryonic antigen in an unselected elderly population: a four year follow-up. Br. J. Cancer 1975, 32, 147–152. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cullen, K J.; Stevens, D P.; Frost, M A.; MacKay, I R. CEA, smoking, and cancer in a longitudinal population study. Aust. N. Z. J. Med. 1976, 6 (4), 279–283. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Anonymous. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J. Clin. Oncol. 1996, 14 (10), 2843–2877.
   PubMed Web of Science ®Google Scholar
• Ladenson, J H.; McDonald, J M.; Landt, M.; Schwartz, M K. Colorectal carcinoma and carcinoembryonic antigen (CEA). Clin. Chem. 1980, 26 (8), 1213–1220. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Staab, H J.; Anderer, F A.; Stumpf, E.; Hornung, A.; Fischer, R.; Kieninger, G. Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am. J. Surg. 1985, 149 (2), 198–204. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ballesta, A M.; Molina, R.; Filella, X.; Jo, J.; Gimenez, N. Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol. 1995, 16 (1), 32–41. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hansen, H J.; Snyder, J J.; Miller, E.; Vanderwoorde, J P.; Miller, O N.; Hines, L R.; Burns, J J. Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Human Pathol. 1974, 5 (2), 139–147.
   PubMed Web of Science ®Google Scholar
• Wolmark, N.; Fisher, B.; Wieand, H S.; Henry, R S.; Lerner, H.; Legault-Poissons, S.; Deckers, P J.; Dimitrov, N.; Gordon, P H.; Jochimsen, P.; Oishi, N. The prognostic significance of preoperative carcinoembryonic antigen levels on colorectal cancer. Results from NSABP clinical trials. Ann. Surg. 1984, 199 (4), 375–382. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jessup, J.; Thomas, P. Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma. Cancer Metastasis Rev. 1984, 8, 263–280.
   Google Scholar
• Slentz, K.; Senagore, A.; Hibbert, J.; Mazier, W P.; Talbott, T M. Can Preoperative and postoperative CEA predict survival after colon cancer resection? Am. Surg. 1994, 60 (7), 528–532. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wichmann, M W. Results of long-term follow-up after resection of Dukes' A colorectal cancer. World J. Surg. 2002, 26 (6), 732–736. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reiter, W.; Stieber, P.; Reuter, L.; Nagel, D.; Lau-Werner, U.; Lamerz, R. Multivariate analysis of the prognosis value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res. 2000, 20 (6D), 5195–5198. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Louhimo, J.; Carpelan-Holmstrom, M.; Alfthan, H.; Stenman, U H.; Jarvinen, H J.; Haglund, C. Serum HCG-beta, CA 72-4, and CEA are independent prognostic factors in colorectal cancer. Int. J. Cancer 2002, 101 (6), 545–548. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Compton, C C.; Fielding, L P.; Burgart, L J.; Conley, B.; Cooper, H S.; Hamilton, S R.; Hammond, M E.; Henson, D E.; Hutter, R N.; Nagle, R B.; Nielsen, M L.; Sargent, D J.; Taylor, C R.; Welton, M.; Willett, C. Prognostic factors in colorectal cancer, College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med. 2000, 124 (7), 979–994. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zamcheck, N. The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis, and evaluation of therapy of colon and pancreatic cancer. Clin. Gastroenterol. 1976, 5 (3), 625–638. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Filella, X.; Molina, R.; Pique, J M.; Grauss, J J.; Garcia-Valdenasas, J C.; Biete, A.; Novell, F.; Astudillo, E.; Bordas, J M.; Campo, E.; de Lacy, A.; Daniels, M.; Ballesta, A M. CEA as a prognostic factor in colorectal cancer. Anticancer Res. 1994, 14 (2B), 705–708. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wiratkapun, S.; Kraemer, M.; Seow-Choen, F.; Ho, Y H.; Euk, W. High preoperative serum CEA predicts metastatic recurrence in potentially curable colon cancer. Dis. Colon Rectum 2001, 44 (2), 231–235. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nakamura, T.; Tabuchi, Y.; Nakae, S.; Ohno, M.; Saitoh, Y. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Cancer 1996, 77 (8 Suppl.), 1741–1746. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Carriquiry, L.; Pineyro, A. Should CEA be used in the management of patients with colorectal cancer? Dis. Colon Rectum 1999, 42 (7), 921–929. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Arnaud, J P.; Koehl, C.; Adloff, M. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis. Colon Rectum 1980, 23 (3), 141–144. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Abad, A.; Font, A.; Pinol, M. Analysis of the clinical prognostic factors in colorectal cancer patients undergoing curative resection. Proc. Am. Soc. Clin. Oncol. 1993, 12, 693a
   Google Scholar
• Boey, J.; Cheung, H C.; Lai, C K.; Wong, J. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma. World J. Surg. 1984, 8 (3), 279–286. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mayer, R J.; Garnick, M B.; Steele, G P.; Zamcheck, N. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer 1978, 42 (Suppl. 3), 1428–1433. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Glover, C.; Douse, P.; Kane, P.; Karani, J.; Meire, H.; Mohammadtaghi, S.; Allen-Mersh, T G. Accuracy of investigation for asymptomatic colorectal liver metastases. Dis. Colon Rectum 2002, 45 (4), 476–484. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sugarbaker, P H.; Gianola, F J.; Dwyer, A. A simplified plan for follow up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 1987, 102, 79–87. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rocklin, M S.; Sengore, A J.; Talbott, T M. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Dis. Colon Rectum 1991, 34, 794–797. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Filella, X.; Molina, R.; Pique, J M.; Garcia-Valdecasas, J C.; Grau, J J.; Novell, F.; Astudillo, E.; de Lacy, A.; Daniels, M L.; Ballesta, A M. Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA. Tumour Biol. 1994, 15 (1), 1–6. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hall, N R.; Finan, P G.; Stephenson, B M.; Purves, D A.; Cooper, E H. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br. J. Cancer 1994, 70 (3), 549–553. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Martin, E W.; Minton, J P.; Carey, L C. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann. Surg. 1983, 202, 310–317.
   Web of Science ®Google Scholar
• Allen-Mersh, T G. Aspects of treatment. Serum CEA in the follow-up of colorectal carcinoma. Experience in a District General Hospital. Ann. L. Coll. Surg. Eng. 1984, 66, 751–755.
   Google Scholar
• Makela, J T.; Laitinen, S O.; Kairaluoma, M I. Five year followup after radical surgery for colorectal cancer—results of a prospective randomized trial. Arch. Surg. 1995, 130, 1062–1067. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lucha, P A., Jr.; Rosen, L.; Olenwine, J A.; Reed, J F., III; Riether, R D.; Stasik, J J., Jr.; Khubchandani, I T. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis. Colon Rectum 1997, 40 (2), 145–149. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Miles, W F.; Greig, J D.; Seth, J.; Sturgeon, C.; Nixon, S J. Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer. Br. J. Gen. Pract. 1995, 45 (395), 287–288. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Minton, J P.; Hoehn, J L.; Gerber, D M. Results of a 400 patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1986, 55, 1284–1290.
   Web of Science ®Google Scholar
• Bruinvels, D J.; Stiggelbout, A M.; Kievit, J.; van Houwelingen, H C.; Habbema, J D.; van de Velde, C J. Follow up of patients with colorectal cancer. Ann. Surg. 1994, 219 (2), 174–182. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Berman, J M.; Cheung, R J.; Weinberg, D S. Surveillance after colorectal cancer resection. Lancet 2000, 355, 395–399. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Klevit, J.; van de Velde, C J. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation: a Markov analysis. Cancer 1990, 65, 2580–2587.
   PubMed Web of Science ®Google Scholar
• Behbehani, A I.; al-Naqeeb, N.; Omar, Y T.; el-Nas, S A.; al-Deen, A S.; Awwad, A.; al-Jazzaf, H.; Nasralla, M Y.; Szymedrea, J J. Serial determinations of serum CEA in monitoring management of patients with colorectal carcinoma. Oncology 1990, 47 (4), 303–307. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Staab, H J.; Anderer, F A.; Hornung, A.; Stumpf, E.; Fischer, R. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br. J. Cancer 1982, 46 (5), 773–781. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Beart, R.; Metzger, P.; O'Connell, M.; Schutt, A. Postoperative screening of patients with carcinoma of the colon. Dis. Colon Rectum 1981, 24, 585–589. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Graham, R A. Postsurgical surveillance of colon cancer—preliminary cost analysis of physician examination, CEA testing, chest xray, and colonoscopy. Ann. Surg. 1998, 228 (1), 59–63. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fletcher, R H. CEA monitoring after surgery for colorectal cancer: when is the evidence sufficient. JAMA 1993, 270, 987–988. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Seregni, E.; Bombardieri, E.; Bogni, A.; Crippa, F.; De Jager, E.; Buraggi, G E. The role of the serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the instituto tumori of Milan. Int. J. Biol. Markers 1992, 7 (3), 167–170. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• McCall, J.; Black, R B.; Rich, C A.; Harvey, J R.; Baker, R A.; Watts, J M.; Toouli, J. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis. Colon Rectum 1994, 37 (9), 875–881. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Staab, H J.; Anderer, F A.; Stumpf, E.; Fischer, R. Slope analysis of postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am. J. Surg. 1978, 136, 322–327. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Carl, J.; Bentzen, S M.; Norgaard-Pederson, B.; Kronberg, O. Modelling of serial carcinoembryonic antigen changes in colorectal cancer. Scand. J. Clin. Lab. Invest. 1993, 53, 751–755. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Umehara, Y.; Kimura, R.; Yoshida, M.; Oba, N.; Harada, Y. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. Cancer 1993, 71, 4055–4059. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kimura, O.; Kaibara, N.; Nishidoi, H.; Okamoto, T.; Takebayashi, M.; Kawasumi, H.; Koga, S. Carcinoembryonic antigen slope as an early indicator for recurrence of colorectal carcinoma. Jpn. J. Surg. 1986, 16 (2), 106–111. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Desch, C E.; Benson, A B., III; Smith, T J.; Flynn, P J.; Krause, C.; Loprinzi, C L.; Minsky, B D.; Petrelli, N J.; Pfister, D G.; Somerfield, M R. Recommended colorectal cancer surveillance guidelines by the american society of clinical oncology. J. Clin. Oncol. 1999, 17 (4), 1312–1321. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Strangl, R.; Altendorf-Hoffman, A.; Charnley, R.; Scheele, J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994, 343, 1405–1410. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hohenberger, P.; Schlag, P.; Gerneth, T.; Herfath, C. Pre- and post-operative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann. Surg. 1994, 219, 135–143. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ishizuka, D.; Shirai, Y.; Sakai, Y.; Hatakeyama, K. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum CEA and carbohydrate antigen 19-9 levels. Int. J. Colorectal Dis. 2001, 16 (1), 32–37. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gervaz, P.; Blanchard, A.; Pampallona, S.; Mach, J P.; Fontolliet, C.; Gillet, M. Postoperative CEA concentration after hepatic resection. Eur. J. Surg. 2000, 166 (7), 557–561. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Preketes, A.; King, J.; Caplehorn, J.; Clingan, P.; Ross, W.; Morris, D. CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Aust. N. Z. J. Surg. 1994, 64, 612–614. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Rena, O.; Casadio, C.; Viano, F.; Cristofori, R.; Ruffini, P L.; Maggi, G. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. A twenty year experience. Eur. J. Cardio-Thorac. Surg. 2002, 21 (5), 906–912. [CSA]
   PubMed Web of Science ®Google Scholar
• Sakamoto, T.; Tsubota, N.; Iwonaga, K.; Yuki, T.; Matsuoka, H.; Yoshimura, M. Pulmonary resection for metastases from colorectal cancer. Chest 2001, 119 (4), 1069–1072. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Saito, Y.; Omiya, H.; Kohno, K.; Kobayashi, T.; Itoi, K.; Teramachi, M.; Sasaki, M.; Suzuki, H.; Takao, H.; Nakade, M. Pulmonary metastatectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J. Thorac. Cardiovasc. Surg. 2002, 124 (5), 1007–1013. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zink, S.; Kayser, G.; Gabius, H J.; Kayser, K. Survival, disease-free interval and associated tumor features in patients with colorectal carcinoma and their resected intra-pulmonary metastases. Eur. J. Cardio-Thorac. Surg. 2001, 19 (6), 908–913. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Sears, H.; Shen, J.; Herlyn, M.; Atkinson, B.; Engstom, P.; Koprowski, H. Circulating tumor markers and assessment of response to intrahepatic chemotherapy of colon carcinoma. Am. J. Clin. Oncol. 1985, 8 (2), 108–117. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Barone, C.; Astone, A.; Cassano, A.; Garufi, C.; Astone, P.; Grieco, A.; Noviello, M R.; Ricevuto, E.; Albanese, C.; Gambassi, G. Advanced colon cancer: staging and prognosis by CEA test. Oncology 1990, 47 (2), 128–132. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Carl, J.; Brunsgaard, N.; Kjaer, M.; Norgaard-Pederson, B. Estimated treatment responses in metastatic colorectal carcinoma based on longitudinal carcinoembryonic antigen series. Scand. J. Clin. Lab. Invest. 1993, 53, 829–834. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Quentmeier, A.; Schlag, P.; Hohenberger, P.; Schwarz, V.; Abel, U. Assessment of serial carcinoembryonic antigen. Determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapy. J. Surg. Oncol. 1989, 40 (2), 112–118. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Herrera, M A.; Chu, T M.; Holyoke, E D.; Mittleman, A. CEA monitoring of palliative treatment for colorectal carcinoma. Ann. Surg. 1977, 185, 23–30. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shani, A.; O'Connell, M J.; Moertel, C G.; Schmitt, A J.; Silvers, A.; Go, V L. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. Ann. Intern. Med. 1978, 88 (5), 627–630. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ward, U.; Primrose, J N.; Finan, P J.; Perren, T J.; Selby, P.; Purves, D A.; Cooper, E H. The Use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br. J. Cancer 1993, 67 (5), 1132–1135. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wang, W S.; Lin, J K.; Lin, T C.; Chiou, T J.; Liu, J H.; Fan, F S.; Yen, C C.; Chen, W S.; Jiang, J K.; Yang, S H.; Wang, H S.; Chen, P M. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer. Int. J. Colorectal Dis. 2001, 16 (2), 96–101. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buroker, T R.; O'Connell, M J.; Wieand, H S.; Krook, J E.; Gerstner, J B.; Mailliard, J A.; Schaefer, P L.; Levitt, R.; Kardinal, C G.; Gesme, D H., Jr. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J. Clin. Oncol. 1994, 12 (1), 14–20. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Glimelius, B. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Ann. Oncol. 1993, 3, 235–240. [CSA]
   Google Scholar
• Figueras, J.; Valls, C.; Rafecas, A.; Fabregat, J.; Ramos, E.; Jaurrieta, E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br. J. Surg. 2001, 88 (7), 980–985. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rothenberg, M L.; Cox, J V.; DeVore, R F.; Hainsworth, J D.; Pazdur, R.; Rivkin, S E.; Macdonald, J S.; Geyer, C E., Jr.; Sandback, J.; Wolf, D L.; Mohrland, J S.; Elfring, G L.; Miller, L L.; von Hoff, D D. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Cancer 1999, 85 (4), 786–795. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Patt, Y Z.; Podoloff, D A.; Curley, S.; Kasi, L.; Smith, R.; Bhadkamkar, V.; Charnsangavej, C. Technetium 99m-labelled IMMU-4, a monoclonal antibody against CEA, for imaging of occult recurrent colorectal cancer in patients with rising serum CEA levels. J. Clin. Oncol. 1994, 12 (3), 489–495. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moffat, F L., Jr.; Pinsky, C M.; Hammershaimb, L.; Petrelli, N J.; Patt, Y Z.; Whaley, F S.; Goldenberg, D M. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. J. Clin. Oncol. 1996, 14 (8), 2295–2305. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• von Mehren, M.; Arlen, P.; Tsang, K Y.; Rogatko, A.; Meropol, N.; Cooper, H S.; Davey, M.; McLaughlin, S.; Schlom, J.; Weiner, L M. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin. Cancer Res. 2000, 6 (6), 2219–2228. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Foon, K A.; Chakraborty, M.; John, W J.; Sherratt, A.; Kohler, H.; Bhattacharya-Chatterjee, M. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. J. Clin. Invest. 1995, 96 (1), 334–342. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Conry, R M.; Curiel, D T.; Strong, T V.; Moore, S E.; Allen, K O.; Barlow, D L.; Shaw, D R.; LoBuglio, A F. Safety and immunogenicity of a DNA vaccine encoding CEA and hepatitis B surface antigen in colorectal carcinoma patients. Clin. Cancer Res. 2002, 8 (9), 2782–2787. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Shively, J E.; Beatty, J D. CEA-related antigens: molecular biology and clinical significance. CRC Crit. Rev. Oncol./Hematol. 1985, 2, 355–399. [CSA]
   PubMed Web of Science ®Google Scholar
• Rogers, G T. Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity. Biochem. Biophys. Acta 1983, 695, 227–249. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Thompson, J.; Zimmerman, W. The carcinoembryonic antigen gene superfamily: structure, expression, and evolution. Tumor Biol. 1988, 9, 63–83.
   PubMed Web of Science ®Google Scholar
• Primus, F J.; Newman, E S.; Hansen, H J. Affinity in radioimmunoassay of antibody cross reactive with carcinoembryonic antigen (CEA) and colon carcinoma antigen-III (CCA-III). J. Immunol. 1977, 115, 55–61.
   Google Scholar
• Rosai, J.; Tillack, T W.; Marchesi, V T. Membrane antigens of human colonic carcinoma and non-tumoral colonic mucosa: results obtained with a new isolation method. Int. J. Cancer 1972, 10, 357–367. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shively, J E.; Todd, C W.; Go, V L.; Egan, M L. Amino-terminal sequence of a carcinoembryonic antigen-like glycoprotein isolated from the colonic lavages of healthy individuals. Cancer Res. 1978, 38 (3), 503–505. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Van Nagell, J R., Jr.; Donaldson, E S.; Gay, E C.; Sharkey, R M.; Rayburn, P.; Goldenberg, D M. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations. Cancer 1978, 41 (6), 2335–2340. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Walstrom, T.; Lindgren, J.; Korhonen, M.; Seppala, M. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine staining of carcinoembryonic antigen in routine histological tissue specimens. Lancet 1979, 2 (8153), 1159–1160. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nakamura, T. Serum CEA levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival. Cancer 1996, 77 (8 Suppl. 1), 1741–1746. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Goslin, R.; O'Brien, M J.; Steele, G. Correlation of plasma CEA and CEA tissue staining in poorly colorectal cancer. Am. J. Med. 1981, 71, 246–249. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Constanza, M E.; Das, S.; Nathanson, L.; Rule, A.; Schwartz, R S. Proceedings: carcinonembryonic antigen. Report of a screening study. Cancer 1974, 33 (2), 583–590.
   PubMed Web of Science ®Google Scholar
• Wichmann, M W.; Lau-Werner, U.; Muller, C.; Hornung, H M.; Stieber, P.; Shildberg, F W. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res. 2000, 20 (6D), 4953–4956. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• van der Schouw, Y T.; Verbeek, A L.; Woobes, T.; Segers, M F.; Thomas, C M. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. Br. J. Surg. 1992, 66 (1), 148–154.
   Web of Science ®Google Scholar
• Yamaguchi, Y.; Kurosaka, Y.; Ishida, T.; Nishimura, G.; Kanno, M.; Kosaka, T.; Yonemura, Y.; Miyazaki, I. Clinical significance of tumor marker NCC-ST 439 in large bowel cancers. Dis. Colon Rectum 1991, 34 (10), 921–924. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Evans, J T.; Mittelman, A.; Chu, M.; Holyoke, E D. Pre- and postoperative uses of CEA. Cancer 1978, 42 (3 Suppl. 1), 1419–1421. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Chu, D Z.; Erickson, C A.; Russell, M P.; Thompson, C.; Lang, N P.; Broadwater, R J.; Westbrook, K C. Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Arch. Surg. 1991, 126 (3), 314–316. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Onetto, M.; Paganuzzi, M.; Secco, G B.; Fardelli, R.; Santi, F.; Rovida, J.; Ferrara, G E. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer. Biomed. Pharmacother. 1985, 39 (7), 392–395. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stahle, E.; Glimellus, B.; Bertstrom, R.; Pahlman, L. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. Eur. J. Surg. Oncol. 1988, 14 (4), 287–296. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Brummendorf, T.; Anderer, F.; Staab, H J.; Hornung, A.; Stumpf, E.; Kieninger, G. Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. J. Surg. Oncol. 1985, 28 (4), 263–269. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kohler, J P.; Simonowitz, D.; Paloyan, D. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma. Am. Surg. 1980, 46, 449–452. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lunde, O.; Havig, O. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum. Acta Chir. Scand. 1982, 148, 189–193. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Tartter, P I.; Slater, G.; Gelernt, I.; Aufses, A H., Jr. Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase. Ann. Surg. 1981, 193, 353–359.
   PubMedGoogle Scholar
• Tomoda, H.; Furusawa, M. The usefulness and limitations of CEA assay in the management of colorectal cancer. Jpn. J. Surg. 1981, 11, 33–38. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Persijn, J P.; Hart, A M. Prognostic significance of CEA in colorectal cancer: a statistical study. Clinical evaluation of carcinoembryonic antigen. J. Clin. Chem. Clin. Biochem. 1981, 19, 1117–1123. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kouri, M.; Pyrhonen, S.; Mecklin, J P.; Jarvinen, H.; Laasonen, A.; Franssila, K.; Kuusela, P.; Nordling, S. Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. Scand. J. Gastroenterol. 1991, 26 (8), 812–818. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bentzen, S M.; Balslev, I.; Pedersen, M.; Teglbjaerg, P S.; Hanberg-Soerensen, F.; Bone, J.; Jacobsen, N O.; Overgaard, J.; Sell, A.; Bertelsen, K.; Hage, E.; Fenger, C.; Kronberg, O.; Hansen, L.; Hoestrup, H.; Noergaard-Pedersen, B. A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative CEA change the prognosis? Br. J. Cancer 1988, 58 (2), 195–201. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fucini, C.; Tommasi, M S.; Cardona, G.; Malatantis, G.; Panichi, S.; Bettini, U. Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer follow-up. Tumori 1983, 69 (4), 359–364. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Szymendera, J J.; Nowacki, M P.; Kozlowica-Gudzinska, I.; Kowalska, M. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. Dis. Colon Rectum 1985, 28 (12), 895–899. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bohm, B.; Schwenk, W.; Hucke, H P.; Stock, W. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis. Colon Rectum 1993, 36 (3), 280–286. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Meling, G I.; Rognum, T O.; Clausen, O P.; Bormer, O.; Lunde, O C.; Schlichting, E.; Gruner, O P.; Hognestad, J.; Trondsen, E.; Havig, O.; Bergan, A. Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients. Scand. J. Gastroenterol. 1992, 27 (12), 1061–1068. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wang, J Y.; Tang, R.; Chiang, J M. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis. Colon Rectum 1994, 37, 272–277. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Albe, X.; Vassilako, P.; Helfer-Guarnori, K.; Givel, J C.; de Quay, N.; Suarder, L.; Eliason, J F.; Odarchenko, N. Independent prognostic value of ploidy in colorectal cancer: a prospective study using image cytometry. Cancer 1990, 66 (6), 1167–1175.
   Google Scholar
• Lim, C N.; McPherson, T A.; McClelland, A R.; McCoy, L.; Koch, M. Value of serial CEA determinations in a surgical adjuvant trial of colorectal and gastric carcinoma. J. Surg. Oncol. 1980, 14 (3), 275–280. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Steele, G.; Zamcheck, N.; Wilson, R.; Mayer, R.; Lokich, J.; Rau, P.; Maltz, J. Results of CEA-initiated second-look surgery for recurrent colorectal cancer. Am. J. Surg. 1980, 139 (4), 544–549. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mariani, G.; Carmellini, M.; Bonaguidi, F.; Benelli, M A.; Toni, M G. Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA. Eur. J. Cancer 1980, 16 (8), 1099–1103. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wood, C B.; Ratcliffe, J G.; Burt, R W.; Malcolm, A J.; Blumgart, L H. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br. J. Surg. 1980, 67 (1), 46–48. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mach, J P.; Vienny, H.; Jaeger, P.; Haldemann, B.; Egely, R.; Pettavel, J. Long-term followup of colorectal carcinoma patients by repeated CEA radioimmunoassay. Cancer 1978, 42 (Suppl. 3), 1439–1447. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Carlsson, U.; Stewonius, J.; Ekelund, G.; Leandoer, L.; Nosslin, B. Is CEA analysis of value in screening for recurrences after surgery for colorectal carcinoma? Dis. Colon Rectum 1983, 26 (6), 369–373. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Attiyeh, F F.; Stearns, M W. Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer 1981, 47, 2119–2125. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• O'Dwyer, P J.; Mojzisik, C.; McCabe, D P.; Farrar, W B.; Carey, L C.; Martin, E W., Jr. Reoperation directed by carcinoembryonic antigen level: the importance of a thorough preoperative evaluation. Am. J. Surg. 1988, 155 (2), 227–231. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Graffner, H.; Hultberg, B.; Johannsson, B.; Moller, T.; Petersson, B G. Detection of recurrent cancer of the colon and rectum. J. Surg.Oncol. 1985, 28 (2), 156–159. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tate, H. Plasma CEA in the post-surgical monitoring of colorectal carcinoma. Br. J. Cancer 1982, 46, 323–330. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Koch, M.; Washer, G.; Gaedke, H.; McPherson, T A. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes' stages B2 and C colorectal cancers. J. Natl. Cancer Inst. 1982, 69 (4), 813–815. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fucini, C.; Tommasi, S M.; Rosi, S. Follow-up of colorectal cancer resected for cure. Dis. Colon Rectum 1987, 30, 273–277. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sandler, R S.; Freund, D A.; Herbst, C A., Jr.; Sandler, D P. Cost effectiveness of postoperative carcinoembryonic antigen monitoring in colorectal cancer. Cancer 1984, 53 (1), 193–198. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hine, K R.; Dykes, P W. Serum CEA testing in the post-operative surveillance of colorectal carcinoma. Br. J. Cancer 1984, 49, 689–693. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kemeny, M M.; Sugarbaker, P H.; Smith, T J.; Edwards, B K.; Shawker, T.; Vermess, M.; Jones, A E. A prospective analysis of laboratory tests and imaging to detect hepatic lesions. Ann. Surg. 1982, 195 (2), 163–167. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moertel, C G.; Schutt, A J.; Go, L W. Carcinoembryonic antigen test for recurrent colorectal cancer. JAMA 1978, 239, 1065–1066. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Steele, J.; Stangl, R.; Altendorf-Hoffman, A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br. J. Surg. 1990, 77, 1241–1246.
   PubMed Web of Science ®Google Scholar
• Morris, D L.; Ross, W B. Australian experience of cryoablation of liver tumors: metastases. Surg. Oncol. Clin. N. Am. 1995, 5 (2), 391–397. [CSA]
   Google Scholar
• Goldenberg, D M. Carcinoembryonic antigen: its role as a marker in the management of cancer: a National Institutes of Health Consensus Development Conference. Ann. Intern. Med. 1981, 94, 407–409.
   PubMed Web of Science ®Google Scholar
• Atkins, C D. Guidelines for the use of carcinoembryonic antigen in colorectal cancer (letter; comment). J. Clin. Oncol. 1997, 15, 863–864. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Carpelan-Holmstrom, M.; Haglund, C.; Lundin, J.; Alfthan, H.; Stenman, U H.; Roberts, P J. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotropin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br. J. Cancer 1996, 74 (6), 925–929. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Guthrie, T H. Carcinoembryonic antigen: the old dog finally learns new tricks (editorial; comment). Dig. Dis. 1996, 14, 1–4. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hida, J.; Yasutomi, M.; Shindoh, K.; Kitauka, M.; Fujimoto, K.; Ieda, S.; Machidera, N.; Kubo, R.; Morikawa, E.; Inufusa, H.; Watatani, M.; Okuno, K. Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques. Dis. Colon Rectum 1996, 39 (1), 74–79. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tobaruela, E.; Enriquez, J M.; Diez, M.; Camunas, J.; Maguerza, J.; Granell, J. Evaluation of serum carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level. Int. J. Biol. Markers 1997, 12 (1), 18–21. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Vauthey, J N.; Dudrick, P S.; Lind, D S.; Copeland, E M., III. Management of recurrent colorectal cancer: another look at carcinoembryonic antigen-detected recurrence. Dig. Dis. 1996, 14 (1), 5–13. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wolf, R F.; Cohen, A M. The minuscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer. J. Am. Coll. Surg. 1997, 185, 60–64. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar